Eligibility for tirzepatide generally requires a BMI threshold (commonly 30, or 27 with at least one comorbidity such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea), no personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, no active pancreatitis history, and no current pregnancy or active pregnancy plan
Can oral medication provide results similar to injections
Epub 2012 Jun 7
Im not here to talk about the pharmaceutical companies, though, Im here to talk about whether or not these medications are safe to take for thyroid patients interested in losing weight
The full name is Glycine-Histidine-Lysine-Copper
Rudolph P, Schubert C, Tamm S, Heidorn K, Hauschild A, Michalska I et al